|52 Week Rng||-|
|P/E Ratio (TTM)||-|
|P/E Ratio (Fwd)||-|
|Div & Yield||-|
Gilead Sciences Short position Constructing our initial portfolio The firm has recently reached its 52-week low so according to our 52-week high/low momentum investment strategy, we expect the firm to be decreasing in value further in the near future due to the negative momentum it is experiencing. (Aiming for a leverage ratio of 1.8)
Short position with this company is suitable with the investment strategy of the fund as it has been in bottom 20 performers among S&P500 companies during the past six months. This transaction facilitates reaching an investment portfolio with equal weights between holdings.